2026 TMU x BE x SCHS Demo Day 以「PULSE HORIZON」為題，聚焦醫療創新的下一道地平線。當臨床需求、科技突破、資本支持與國際市場彼此匯流，醫療新創的每一次驗證、每一次落地、每一次跨境拓展，都是推動未來醫療持續前進的關鍵脈動。
本屆 Demo Day 將呈現 10 組來自台灣、美國、加拿大、韓國、日本、新加坡、英國的醫療科技新創，涵蓋 AI 醫療影像、臨床決策輔助、手術科技、數位療法、遠距復健、認知照護、非接觸式監測與連續生理量測等多元領域。這些團隊不僅代表前瞻技術的展示，更展現醫療新創從產品開發、臨床驗證到市場導入的真實推進歷程。
【活動資訊】
▸活動名稱：TMUｘBEｘSCHS Demoday：PULSE HORIZON
▸活動日期：12:30－16:00（12:30開放入場，13:00活動開始）
▸活動地點：南港展覽館1館 504會議室（台北市南港區經貿二路1號）
歡迎對醫療科技與創業投資有興趣的產業相關夥伴一起來共襄盛舉!
【活動亮點】
✔ 10 組來自台灣、美國、加拿大、韓國、日本、新加坡、英國醫療科技新創，展現跨國醫療創新能量
✔ 聚焦 AI、手術科技、數位療法、遠距照護與醫療監測等高潛力領域
✔ 串聯北醫與秀傳臨床場域，推動新創從技術展示走向臨床驗證
✔ 連結投資人、醫療體系、產業夥伴與國際網絡，探索台灣醫療科技的下一道地平線
✔ 透過 Demo Day 與現場交流，看見醫療創新的脈動如何從台灣延伸至全球市場
本次活動亦延續比翼生醫、臺北醫學大學與秀傳醫療體系自 2018 年以來共同打造的醫療創新平台，透過臨床場域、醫師資源、產業輔導與投資網絡，協助新創將技術能量轉化為可被驗證、可被採用、並具備國際拓展潛力的醫療解決方案。
【Startups】
Startup | Country | Abstract |
RADAX.AI | Taiwan | Developing AI brain imaging assisted detection software to help physicians identify 3mm intracranial aneurysms in TOF-MRA images, improving diagnostic efficiency and reducing the risk of missed diagnoses. |
Aulea Medical | USA | FDA 510(k)-cleared disposable surgical instruments for BPH(Benign Prostatic Hyperplasia). Improving surgical efficiency, reducing bleeding, and decreasing the need for hospitalization. |
Machnet Robotics | Singapore, UK | Developing a cardiovascular interventional surgical robotic platform to assist in interventions like PCI, reducing operational variability, physician fatigue, and radiation exposure. |
Luminopia | USA | First FDA-authorized (De Novo) VR digital therapeutic for pediatric amblyopia. Kids watch modified shows that force both eyes to work via dichoptic masking; now in AAO guidelines with 11,000+ prescriptions. |
Xandar Kardian | USA, Canada, Korea | First with FDA 510(k) clearance for radar-based resting heart-rate and respiration monitoring. It’s fully contactless (no wearables, no patient compliance), shown to cut long-term-care readmissions, applicable in hospital, LTC, and home RPM. |
AISI X | Japan | Developing a multimodal AI imaging triage assistant to help identify abnormalities in brain CT/MRI, prioritize urgent cases, and generate draft reports. |
MacroInsight Innovation | Taiwan | Developing an AI mammography image quality review system to assist radiographers in instantly assessing image quality in 2 seconds, reducing retakes and reading risks. Runs fully on-prem with seamless PACS integration. |
Omnilabs Research | Singapore | Developing tele-rehabilitation devices combining music therapy, smart assistive robots, and XR technology to support rehab training and remote monitoring. |
RadiRad | Taiwan | Cuffless finger-clip continuous blood pressure monitoring device that turns a single PPG signal into four cardiovascular readings that provides cardiovascular information such as blood pressure, heart rate, SpO₂, and HRV. |
Brainmate | Taiwan | Developing an AI cognitive assessment and treatment system that covers the full dementia pathway, including screening, assessment, personalized treatment, and follow-up. |
【Panel Discussion】
❏ Topic: Reimagining Healthcare — The Next Frontier for Innovation, Investment and Adoption
✦Moderator:
✧Dr. Yvette Lu｜Investment Director for Europe , BE Health Ventures
呂宜蒨博士現任 BE Health Ventures 歐洲投資總監，負責海外投資布局，並協助創新醫療企業鏈結亞洲臨床、市場及策略合作夥伴，加速國際發展。她畢業於英國牛津大學醫學科學博士，曾任職於野村證券、鴻海科技集團及緯創集團，擁有創投、投資銀行併購、醫療科技先進製造及企業策略等跨領域經驗。她長期致力於透過投資、跨國合作與策略夥伴關係，推動全球醫療創新的發展。
✦Panelist:
✧Christopher Potts｜Chief Business Officer, Persephoni BioPartners
Christopher Potts 為現任美國生技創投工作室 Persephoni Bio 首席商務長，該機構專注於培育次世代先進療法企業。同時，他也是 Monarch Therapeutics 創辦人暨執行長，該公司致力於開發治療固形腫瘤的 CAR-T 細胞療法。他在生物技術、智慧財產權、授權合作及策略夥伴關係建立等領域具備豐富經驗，並長期推動全球生技生態圈中的跨國合作與創新連結。
✧ Dr. Jaemin Park｜Managing Partner, Heal Venture Lab
Jaemin Park 醫師是一位兼具臨床醫學、私募股權及跨境生命科學領域專業的醫師型企業領袖與企業創建者。作為 Heal Venture Lab（HVL）的創辦管理合夥人，他帶領團隊在亞太地區推動醫療加速器與創投孵化相關計畫，促進醫療創新發展。他專精於醫療投資與生命科學商業化，致力於扶植新興醫療科技企業成長，並推動跨境醫療創新合作。
✧ Rudi Pauwels｜Praesens Foundation 共同創辦人兼主席
Rudi Pauwels 是比利時藥學科學家、病毒學家與連續生技創業家，目前為 Praesens Foundation 共同創辦人兼主席，並曾共同創辦 Tibotec、Virco、Galapagos Genomics 與 Biocartis。
他的職涯橫跨抗病毒藥物研發、分子診斷、個人化醫療與生技創業，具備從科研到公司建立、再到產品化與國際化的完整經驗。
✧ Yiu-Lian Fong｜DxRxPM Biotech Consulting 創辦人
馮玉蓮Yiu-Lian Fong, PhD, MBA 目前為 DxRxPM Biotech Consulting 創辦人，並擔任 MiRXES 的 Senior Scientific & Corporate Strategy Advisor。
她擁有橫跨 pharmaceutical、biotech 與 IVD 的資深研發與策略背景，專長涵蓋 vaccine 與 therapeutic drug development、clinical biomarkers、clinical trial assays、companion/complementary diagnostics，以及 Dx/Rx co-development。
她曾於 Janssen / Johnson & Johnson 擔任全球診斷創新與 biomarker strategy 領導職務，也曾在 Abbott、Novartis、Chiron 與 Johns Hopkins University 擔任重要研發職位，並具備多項國際法規申報與精準醫療策略經驗。
【Organizers】
➣臺北醫學大學 TMU BioMed Accelerator
臺灣首家國際級創新醫療大學加速器，專注於「數位醫療」、「人工智慧」、與「醫療器材」三大主題，整合臺北醫學大學完善的醫療臨床體系資源，協助新創臨床試驗規劃並建立醫療通路、商業模式、創業資金募集、新創社群與國際資源的鏈結、輔導團隊降低產品開發風險，並善用北醫完善的醫療臨床場域與專業醫師，導入北醫大數據處，包含臨床資料庫、健保資料庫、臨床數據中心等，提供優質的數據服務，以及北醫大人體研究處，輔導新創團隊產品臨床試驗的研發策略，使新創團隊加速研究成果商品化並鏈結國際生態圈。
➣比翼生醫 BE Health
比翼生醫（BE Health）是一家專注於投資創新醫療科技的「醫院創投」，同時也是台灣最大的醫療生技新創加速器。自2018年成立以來，已輔導100+具影響力且前瞻性的新創團隊，並協助其籌得超過1.5億美元資金。我們專注於創新醫材與數位醫療領域，運用台灣為全球醫療新創進入亞洲市場的橋樑，與全球重量級醫療體系、研究機構、投資者和生技專家夥伴緊密合作，於嚴峻棘手的醫療領域建構國際生態系統，共同努力協助新創成長為顛覆性企業。我們的使命為與生態系的夥伴協力培育優秀的醫療新創團隊，推動創新醫療科技，提供患者更好的醫療體驗。
➣秀傳醫療體系Show Chwan Healthcare System
秀傳醫療體系是臺灣目前最大的的私人醫療集團，擁有50年的醫療專業經驗，在全台擁有10家醫院、4500多張床位與7000多名員工。由黃明和總裁創立以來，使命即期望將領先的技術和服務提供至資源不足的地區。
近年來，我們專注於智慧科技應用，例如人工智慧整合、手術數位化以及個人健康和居家護理物聯網設備。秀傳醫療集團以旗下醫院為示範基地，致力於打造國際化的人工智慧手術訓練中心，引領亞洲醫療數位轉型。我們加速醫療科技創新進程，涵蓋研發、效能驗證、法規認證和國際市場推廣。
➣秀傳亞洲遠距微創手術訓練中心 IRCAD-Taiwan
IRCAD遠距微創手術中心於1994年在法國史特拉斯堡成立，結合尖端科技與國際知名專家學者，致力於外科醫師的培育與訓練。透過與秀傳醫療體系的合作，亞洲遠距微創手術中心（AITS／IRCAD Taiwan）於2008年成立，延續歐洲遠距微創手術中心（EITS／IRCAD）的精神，為亞洲外科醫師提供最優質的教育與訓練模式。截至目前，IRCAD Taiwan 已經培訓來自全球70多個國家、超過25,000名學員。透過循序漸進的手術示範，以及現場動物實驗和大體實驗，IRCAD Taiwan 為亞洲外科醫師帶來最高品質的教育。
【Agenda】
12:30 - 13:00 | 報到 |
| 13:00 - 13:30 | 開場＆貴賓致詞 |
| 13:30 - 13:35 | 大合照 |
| 13:35 - 13:40 | 加速器介紹 |
| 13:40 - 14:50 | 新創發表（5min each） |
| 14:50 - 15:20 | 座談會 |
| 15:20 - 16:00 | 閉幕＆交流時間 |
The 2026 TMU x BE x SCHS Demo Day, themed "PULSE HORIZON," focuses on the next horizon of medical innovation. As clinical needs, technological breakthroughs, capital support, and international markets converge, every validation, real-world implementation, and cross-border expansion by medical startups represents a critical pulse driving the future of healthcare forward.
This year's Demo Day will feature 10 MedTech startups from Taiwan, the United States, and Singapore, Canada, Japan, Korea, UK covering diverse fields such as AI medical imaging, clinical decision support, surgical technology, digital therapeutics, tele-rehabilitation, cognitive care, contactless monitoring, and continuous physiological measurement.
These teams not only represent a showcase of forward-looking technologies but also demonstrate the real-world progression of medical startups from product development and clinical validation to market adoption.
[Event Information]
Event Name: TMU x BE x SCHS Demo Day：PULSE HORIZON
Time: 12:30 – 16:00 (Admission starts at 12:30; Event begins at 13:00)
Venue: Room 504, Taipei Nangang Exhibition Center, Hall 1 (No. 1, Jingmao 2nd Rd., Nangang Dist., Taipei City)
We welcome industry partners interested in MedTech and venture capital to join us for this grand event!
[Event Highlights]
✔ 10 MedTech startups from Taiwan, the United States, and Singapore, Canada, Japan, Korea,UK showcasing transnational medical innovation capabilities.
✔ A focus on high-potential fields including AI, surgical technology, digital therapeutics, remote care, and medical monitoring.
✔ Connecting clinical testing grounds of Taipei Medical University (TMU) and Show Chwan Health Care System (SCHS) to propel startups from technical demonstration to clinical validation.
✔ Linking investors, healthcare systems, industry partners, and international networks to explore the next horizon of Taiwan's MedTech sector.
✔ Discovering through the Demo Day and on-site networking how the pulse of medical innovation extends from Taiwan to the global market.
【Startups】
Startup | Country | Abstract |
RADAX.AI | Taiwan | Developing AI brain imaging assisted detection software to help physicians identify 3mm intracranial aneurysms in TOF-MRA images, improving diagnostic efficiency and reducing the risk of missed diagnoses. |
Aulea Medical | USA | FDA 510(k)-cleared disposable surgical instruments for BPH(Benign Prostatic Hyperplasia). Improving surgical efficiency, reducing bleeding, and decreasing the need for hospitalization. |
Machnet Robotics | Singapore, UK | Developing a cardiovascular interventional surgical robotic platform to assist in interventions like PCI, reducing operational variability, physician fatigue, and radiation exposure. |
Luminopia | USA | First FDA-authorized (De Novo) VR digital therapeutic for pediatric amblyopia. Kids watch modified shows that force both eyes to work via dichoptic masking; now in AAO guidelines with 11,000+ prescriptions. |
Xandar Kardian | USA, Canada, Korea | First with FDA 510(k) clearance for radar-based resting heart-rate and respiration monitoring. It’s fully contactless (no wearables, no patient compliance), shown to cut long-term-care readmissions, applicable in hospital, LTC, and home RPM. |
AISI X | Japan | Developing a multimodal AI imaging triage assistant to help identify abnormalities in brain CT/MRI, prioritize urgent cases, and generate draft reports. |
MacroInsight Innovation | Taiwan | Developing an AI mammography image quality review system to assist radiographers in instantly assessing image quality in 2 seconds, reducing retakes and reading risks. Runs fully on-prem with seamless PACS integration. |
Omnilabs Research | Singapore | Developing tele-rehabilitation devices combining music therapy, smart assistive robots, and XR technology to support rehab training and remote monitoring. |
RadiRad | Taiwan | Cuffless finger-clip continuous blood pressure monitoring device that turns a single PPG signal into four cardiovascular readings that provides cardiovascular information such as blood pressure, heart rate, SpO₂, and HRV. |
Brainmate | Taiwan | Developing an AI cognitive assessment and treatment system that covers the full dementia pathway, including screening, assessment, personalized treatment, and follow-up. |
【Panel Discussion】
❏ Topic: Reimagining Healthcare — The Next Frontier for Innovation, Investment and Adoption
✦Moderator:
✧Dr. Yvette Lu｜Investment Director for Europe , BE Health Ventures
Dr. Yvette Lu is Investment Director for Europe at BE Health Ventures, where she leads European investment activities and helps connect innovative healthcare companies with strategic partners across Asia. She holds a DPhil in Medical Sciences from the University of Oxford and has held roles spanning venture capital, healthcare investment banking, medical technology and advanced manufacturing, and corporate strategy at organizations including Nomura, Foxconn, and Wistron. Her work focuses on advancing global healthcare innovation through investment, strategic partnerships, and international collaboration.
✦Panelist:
✧Christopher Potts｜Chief Business Officer, Persephoni BioPartners
Christopher Potts is the Chief Business Officer of Persephoni Bio, a U.S.-based biotech venture studio focused on developing next-generation advanced therapy companies. He is also the Founder and CEO of Monarch Therapeutics, specializing in solid tumor CAR-T cell therapy development. With expertise spanning biotechnology, intellectual property, licensing, and strategic partnerships, he supports global collaborations across the biotech ecosystem.
✧ Dr. Jaemin Park｜Managing Partner, Heal Venture Lab
Dr. Jaemin Park is a physician-executive and venture builder with expertise across clinical medicine, private equity, and cross-border life sciences. As the Founding Managing Partner of Heal Venture Lab (HVL), he leads healthcare acceleration and venture building initiatives across the Asia-Pacific region. He specializes in healthcare investment and life science commercialization, supporting the growth of emerging medical technology companies and advancing healthcare innovation.
✧ Rudi Pauwels｜Praesens Foundation 共同創辦人兼主席
Rudi Pauwels is a Belgian pharmaceutical scientist, virologist, and serial biotech entrepreneur. He is currently the Co-founder and Chairman of the Praesens Foundation, and has previously co-founded Tibotec, Virco, Galapagos Genomics, and Biocartis.
His career spans antiviral drug development, molecular diagnostics, personalized medicine, and biotech entrepreneurship, giving him comprehensive experience from scientific research and company building to product commercialization and international expansion.
✧ Yiu-Lian Fong｜DxRxPM Biotech Consulting 創辦人
Yiu-Lian Fong, PhD, MBA, is the Founder of DxRxPM Biotech Consulting and currently serves as Senior Scientific & Corporate Strategy Advisor at MiRXES.
She brings extensive R&D and strategic leadership experience across the pharmaceutical, biotech, and IVD sectors. Her expertise spans vaccine and therapeutic drug development, clinical biomarkers, clinical trial assays, companion and complementary diagnostics, and Dx/Rx co-development.
She previously held global leadership roles in diagnostic innovation and biomarker strategy at Janssen / Johnson & Johnson, and has also served in key R&D positions at Abbott, Novartis, Chiron, and Johns Hopkins University. She has extensive experience in international regulatory submissions and precision medicine strategy.
【Organizers】
➣臺北醫學大學 TMU BioMed Accelerator
Taiwan's first international innovative medical university accelerator, with a well-established medical market, clinical resources, biomedical and artificial intelligence talents. TMU focus on three themes of "digital medicine", "artificial intelligence" and "medical equipment", assisting startups in fundraising, linking new communities with international resources, reducing product development risks, establishing medical pathways with clinical trials. TMU leverage the expertise of our physicians, to guide the team's products in clinical trials, so as to accelerate the commercialization of research results and link the international ecosystem.
➣比翼生醫 BE Health
BE Health is a "hospital VC" dedicated to investing in innovative medical technology. It is also the largest medtech and healthtech startup accelerator in Taiwan. Since our establishment in 2018, BE Health has mentored over 100 influential and forward-thinking startup teams, helping them raise over $150 million in funding. We focus on innovative medical devices and digital healthcare, utilizing Taiwan as a gateway for global medical startups to enter the Asian market. We work closely with prestigious healthcare systems, research institutions, investors, and biotech experts worldwide to build an international ecosystem in the challenging and complex field of healthcare. We work together to assist startups in their growth journey, aiming to transform them into disruptive enterprises. Our mission is to collaborate with ecosystem partners in nurturing exceptional medical startup teams and driving innovative medical technology to provide patients with better healthcare experience.
➣秀傳醫療體系Show Chwan Healthcare System
Show Chwan is a hand-in-hand “family” healthcare system. With 50 years of medical expertise. Show Chwan Health Care System operates 10 hospitals with a current number of 4500 beds, and 7000 employees. President Huang Min-Ho advocates the spirit of “Mayo Clinic” by establishing a “sound rural hospital” system, allowing even the people in the most remote of areas to enjoy the quality and cordial medical care found in cosmopolitan cities. In recent years, our focus has been on smart technology applications such as artificial intelligence integration, digital surgery, and remote care IoT devices for personal health and home care. These applications span clinical healthcare, nursing care, and continuous care for discharged patients.
Using its hospitals as demonstration sites, Show Chwan Health Care System is dedicated to establishing an international AI surgical training center, spearheading the digital transformation of healthcare in Asia. We accelerate progress in medical technology innovation, covering research and development, efficacy confirmation, regulatory certification, and international marketing.
➣秀傳亞洲遠距微創手術訓練中心 IRCAD-Taiwan
IRCAD, established in Strasbourg, France in 1994, combines cutting-edge technology with renowned experts and scholars, and is dedicated to cultivating and training surgeons. Through collaboration with the Show Chwan Healthcare System, the Asian Institute of Telesurgery (AITS / IRCAD Taiwan) was established in 2008, continuing the efforts of the European Institute of Telesurgery (EITS / IRCAD) to provide the best educational and training model for Asian surgeons. To date, IRCAD Taiwan has trained over 25,000 participants from more than 70 countries worldwide. Through step-by-step surgical demonstrations, as well as live animal and cadaver labs, IRCAD Taiwan delivers the highest quality education to surgeons across Asia.
【Agenda】
12:30 - 13:00 | Registration |
| 13:00 - 13:30 | Opening & Guest Remarks |
| 13:30 - 13:35 | Group Photo |
| 13:35 - 13:40 | Intro |
| 13:40 - 14:50 | Pitch Session |
| 14:50 - 15:20 | Panel Discussion |
| 15:20 - 16:00 | Closing & Networking |
